Luba, R., Madera, G., Schusterman, R., Kolodziej, A., Hodgson, I., & Comer, S. D. (2024). Evaluating the Abuse Potential of Lenabasum, a Selective CB2 Cannabinoid Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics, JPET-AR-2024-002129. https://doi.org/10.1124/jpet.124.002129

Sánchez-Rico, M., Edán-Sánchez, A., Olfson, M., Alvarado, J. M., Airagnes, G., Rezaei, K., Delcuze, A., Peyre, H., Limosin, F., & Hoertel, N. (2023). Antipsychotic use and 28-day mortality in patients hospitalized with COVID-19: A multicenter observational retrospective study. European Neuropsychopharmacology, 75, 93–104. https://doi.org/10.1016/j.euroneuro.2023.06.005

Clelland, C. L., Ramiah, K., Steinberg, L., & Clelland, J. D. (2021). Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort. BJPsych Open, 8(1). https://doi.org/10.1192/bjo.2021.1053